Fidelity Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $647M | Buy |
10,671,103
+420,797
| +4% | +$24.5M | 0.03% | 422 |
|
|
2025
Q4 | $553M | Sell |
10,250,306
-48,854
| -0.5% | -$2.35M | 0.03% | 473 |
|
|
2025
Q3 | $464M | Sell |
10,299,160
-5,929,008
| -37% | -$277M | 0.02% | 534 |
|
|
2025
Q2 | $751M | Sell |
16,228,168
-5,393,258
| -25% | -$265M | 0.04% | 355 |
|
|
2025
Q1 | $1.32B | Sell |
21,621,426
-9,489,393
| -31% | -$553M | 0.08% | 198 |
|
|
2024
Q4 | $1.76B | Sell |
31,110,819
-13,829,790
| -31% | -$773M | 0.11% | 148 |
|
|
2024
Q3 | $2.33B | Buy |
44,940,609
+4,275,787
| +11% | +$201M | 0.14% | 119 |
|
|
2024
Q2 | $1.69B | Sell |
40,664,822
-1,900,380
| -4% | -$85M | 0.11% | 142 |
|
|
2024
Q1 | $2.31B | Sell |
42,565,202
-47,264
| -0.1% | -$2.41M | 0.16% | 99 |
|
|
2023
Q4 | $2.19B | Sell |
42,612,466
-408,427
| -0.9% | -$21.4M | 0.17% | 96 |
|
|
2023
Q3 | $2.5B | Sell |
43,020,893
-3,724,478
| -8% | -$228M | 0.22% | 69 |
|
|
2023
Q2 | $2.99B | Sell |
46,745,371
-2,559,232
| -5% | -$172M | 0.25% | 57 |
|
|
2023
Q1 | $3.42B | Sell |
49,304,603
-9,806,911
| -17% | -$692M | 0.31% | 51 |
|
|
2022
Q4 | $4.25B | Sell |
59,111,514
-10,788,770
| -15% | -$813M | 0.42% | 33 |
|
|
2022
Q3 | $4.97B | Sell |
69,900,284
-1,982,152
| -3% | -$144M | 0.52% | 26 |
|
|
2022
Q2 | $5.53B | Buy |
71,882,436
+4,855,169
| +7% | +$370M | 0.55% | 21 |
|
|
2022
Q1 | $4.9B | Buy |
67,027,267
+10,502,079
| +19% | +$705M | 0.39% | 36 |
|
|
2021
Q4 | $3.52B | Sell |
56,525,188
-4,879,179
| -8% | -$286M | 0.26% | 58 |
|
|
2021
Q3 | $3.63B | Sell |
61,404,367
-7,071,495
| -10% | -$466M | 0.29% | 48 |
|
|
2021
Q2 | $4.58B | Buy |
68,475,862
+8,919,562
| +15% | +$582M | 0.36% | 37 |
|
|
2021
Q1 | $3.76B | Buy |
59,556,300
+295,503
| +0.5% | +$18.4M | 0.32% | 45 |
|
|
2020
Q4 | $3.68B | Sell |
59,260,797
-3,365,228
| -5% | -$207M | 0.33% | 45 |
|
|
2020
Q3 | $3.78B | Sell |
62,626,025
-2,957,096
| -5% | -$178M | 0.38% | 37 |
|
|
2020
Q2 | $3.86B | Sell |
65,583,121
-3,418,291
| -5% | -$204M | 0.42% | 34 |
|
|
2020
Q1 | $3.85B | Sell |
69,001,412
-3,420,308
| -5% | -$209M | 0.53% | 24 |
|
|
2019
Q4 | $4.65B | Buy |
72,421,720
+22,132,025
| +44% | +$1.27B | 0.51% | 26 |
|
|
2019
Q3 | $2.55B | Sell |
50,289,695
-2,576,819
| -5% | -$121M | 0.31% | 56 |
|
|
2019
Q2 | $2.4B | Buy |
52,866,514
+12,014,627
| +29% | +$560M | 0.28% | 59 |
|
|
2019
Q1 | $1.95B | Buy |
40,851,887
+30,981,844
| +314% | +$1.54B | 0.23% | 74 |
|
|
2018
Q4 | $513M | Sell |
9,870,043
-24,274
| -0.2% | -$1.3M | 0.07% | 272 |
|
|
2018
Q3 | $614M | Sell |
9,894,317
-2,686,172
| -21% | -$159M | 0.07% | 270 |
|
|
2018
Q2 | $696M | Sell |
12,580,489
-6,321,770
| -33% | -$341M | 0.08% | 234 |
|
|
2018
Q1 | $1.2B | Sell |
18,902,259
-6,426,965
| -25% | -$413M | 0.14% | 143 |
|
|
2017
Q4 | $1.55B | Sell |
25,329,224
-5,579,781
| -18% | -$349M | 0.18% | 106 |
|
|
2017
Q3 | $1.97B | Sell |
30,909,005
-5,684,461
| -16% | -$332M | 0.24% | 73 |
|
|
2017
Q2 | $2.04B | Sell |
36,593,466
-6,566,770
| -15% | -$357M | 0.25% | 69 |
|
|
2017
Q1 | $2.35B | Sell |
43,160,236
-2,162,438
| -5% | -$119M | 0.3% | 60 |
|
|
2016
Q4 | $2.65B | Sell |
45,322,674
-1,500,498
| -3% | -$82M | 0.35% | 48 |
|
|
2016
Q3 | $2.52B | Sell |
46,823,172
-9,977,810
| -18% | -$641M | 0.34% | 53 |
|
|
2016
Q2 | $4.18B | Sell |
56,800,982
-1,591,566
| -3% | -$112M | 0.57% | 25 |
|
|
2016
Q1 | $3.73B | Buy |
58,392,548
+8,337,135
| +17% | +$526M | 0.52% | 31 |
|
|
2015
Q4 | $3.44B | Sell |
50,055,413
-922,241
| -2% | -$60.9M | 0.46% | 35 |
|
|
2015
Q3 | $3.02B | Sell |
50,977,654
-787,398
| -2% | -$50M | 0.43% | 38 |
|
|
2015
Q2 | $3.44B | Buy |
51,765,052
+6,090,554
| +13% | +$401M | 0.44% | 35 |
|
|
2015
Q1 | $2.95B | Buy |
45,674,498
+841,201
| +2% | +$52.7M | 0.38% | 44 |
|
|
2014
Q4 | $2.65B | Buy |
44,833,297
+7,550,008
| +20% | +$426M | 0.34% | 51 |
|
|
2014
Q3 | $1.91B | Buy |
37,283,289
+3,046,575
| +9% | +$152M | 0.26% | 74 |
|
|
2014
Q2 | $1.66B | Sell |
34,236,714
-12,430,216
| -27% | -$613M | 0.22% | 90 |
|
|
2014
Q1 | $2.42B | Buy |
46,666,930
+28,213,799
| +153% | +$1.5B | 0.34% | 56 |
|
|
2013
Q4 | $981M | Buy |
18,453,131
+4,924,573
| +36% | +$251M | 0.14% | 164 |
|
|
2013
Q3 | $626M | Sell |
13,528,558
-827,668
| -6% | -$36.3M | 0.1% | 245 |
|
|
2013
Q2 | $642M | Buy |
+14,356,226
| New | +$623M | 0.11% | 215 |
|
Other funds holding BMY
VCM
VPM
Fidelity Investments's BMY Position: Q1 2026 in Review
Fidelity Investments increased its Bristol-Myers Squibb (BMY) stake by 4.1% in Q1 2026, buying an estimated $24.5M and bringing the position to 10,671,103 shares worth $647M. The position accounts for 0.03% of the portfolio, ranked #422.
Fidelity Investments first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.53B in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Fidelity Investments held 10,671,103 shares of Bristol-Myers Squibb worth $647M as of Q1 2026.
- Fidelity Investments bought 420,797 Bristol-Myers Squibb shares in Q1 2026, an estimated $24.5M.
- Bristol-Myers Squibb made up 0.03% of Fidelity Investments's portfolio in Q1 2026, its #422 holding.
- Fidelity Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Bristol-Myers Squibb position peaked at $5.53B in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.